Cartilage oligomeric matrix protein as a potential biomarker for knee osteoarthritis
Issued Date
2024-06-01
Resource Type
eISSN
20463758
Scopus ID
2-s2.0-85197418720
Journal Title
Bone and Joint Research
Volume
13
Issue
6
Start Page
261
End Page
271
Rights Holder(s)
SCOPUS
Bibliographic Citation
Bone and Joint Research Vol.13 No.6 (2024) , 261-271
Suggested Citation
Udomsinprasert W., Mookkhan N., Tabtimnark T., Aramruang T., Ungsudechachai T., Saengsiwaritt W., Jittikoon J., Chaikledkaew U., Honsawek S. Cartilage oligomeric matrix protein as a potential biomarker for knee osteoarthritis. Bone and Joint Research Vol.13 No.6 (2024) , 261-271. 271. doi:10.1302/2046-3758.136.BJR-2023-0180.R1 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/99611
Title
Cartilage oligomeric matrix protein as a potential biomarker for knee osteoarthritis
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
Aims This study aimed to determine the expression and clinical significance of a cartilage protein, cartilage oligomeric matrix protein (COMP), in knee osteoarthritis (OA) patients. Methods A total of 270 knee OA patients and 93 healthy controls were recruited. COMP messenger RNA (mRNA) and protein levels in serum, synovial fluid, synovial tissue, and fibroblast-like synoviocytes (FLSs) of knee OA patients were determined using enzyme-linked immunosorbent assay, real-time polymerase chain reaction, and immunohistochemistry. Results COMP protein levels were significantly elevated in serum and synovial fluid of knee OA patients, especially those in the advanced stages of the disease. Serum COMP was significantly correlated with radiological severity as well as measures of body composition, physical performance, knee pain, and disability. Receiver operating characteristic curve analysis unveiled a diagnostic value of serum COMP as a biomarker of knee OA (41.64 ng/ml, area under the curve (AUC) = 1.00), with a sensitivity of 99.6% and a specificity of 100.0%. Further analysis uncovered that COMP mRNA expression was markedly upregulated in the inflamed synovium of knee OA, consistent with immunohistochemical staining revealing localization of COMP protein in the lining and sub-lining layers of knee OA inflamed synovium. Most notably, relative COMP mRNA expression in knee OA synovium was positively associated with its protein levels in serum and synovial fluid of knee OA patients. In human knee OA FLSs activated with tumour necrosis factor-alpha, COMP mRNA expression was considerably up-regulated in a time-dependent manner. Conclusion All results indicate that COMP might serve as a supportive diagnostic marker for knee OA in conjunction with the standard diagnostic methods.